The economic burden of cancer in Korea in 2002
Authors:
- 28 September 2007
- journal article
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 17 (2) , 136-144
Abstract
Cancer is the leading cause of death and one of the most significant healthcare expenses in Korea. The purpose of this study was to estimate the economic burden of cancer on Korean society. We studied the medical, non-medical, morbidity and mortality costs related to cancer treatment, lost productivity and premature death. Healthcare claims for 2002 obtained from the Health Insurance Review Agency were used to estimate medical expenditures; these were linked with the Korean Central Cancer Registry database to identify cancer patients. The number of deaths used to estimate mortality costs was obtained from the Annual Report of Mortality from the National Statistics Office of Korea. Moreover, data from the Korean National Statistics Office and Ministry of Labor were used to calculate life expectancy at the age of death, labour force participation, and average age- and gender-specific earnings. In 2002, the estimated total economic cost of cancer amounted to $9.4 billion (1.72% of GDP) at a 3% discount rate. Medical care costs amounted to 13.7% of total costs, non-medical costs 6.5%, morbidity costs 14.5%, and mortality costs accounted for 65.3%. Increased prevention, earlier diagnosis, new therapies and effective cancer control policies are needed to reduce the economic burden of cancer in Korea.Keywords
This publication has 16 references indexed in Scilit:
- Cost of illness of malignant lymphoma in GermanyEuropean Journal of Cancer Care, 2006
- Cost of Lung CancerPharmacoEconomics, 2006
- Cost of Illness and its Predictors for Parkinson??s Disease in GermanyPharmacoEconomics, 2005
- Burden of Illness in Cancer Survivors: Findings From a Population-Based National SampleJNCI: Journal of the National Cancer Institute, 2004
- Management of Dyslipidemia in Children and Adolescents With DiabetesDiabetes Care, 2003
- Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare DataMedical Care, 2002
- The economic burden of prostate cancer, California, 1998Cancer, 2002
- Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service SettingsJournal of Clinical Oncology, 2002
- The Relation between Funding by the National Institutes of Health and the Burden of DiseaseNew England Journal of Medicine, 1999
- Persons with chronic conditions. Their prevalence and costs1996